BRIEF-Aveo Oncology Q3 loss per share $0.07
November 04, 2016 at 07:27 AM EDT
* Says believe that $30.8 million in cash resources could allow to fund planned operations into Q4 of 2017
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.